Pacer Advisors Inc. Has $388.31 Million Holdings in HCA Healthcare, Inc. $HCA

Pacer Advisors Inc. lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6,115.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 911,096 shares of the company’s stock after purchasing an additional 896,437 shares during the period. HCA Healthcare accounts for approximately 1.0% of Pacer Advisors Inc.’s investment portfolio, making the stock its 28th biggest holding. Pacer Advisors Inc. owned approximately 0.39% of HCA Healthcare worth $388,309,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new position in shares of HCA Healthcare in the second quarter valued at about $1,152,408,000. Viking Global Investors LP increased its holdings in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Nordea Investment Management AB increased its stake in HCA Healthcare by 6.8% during the 2nd quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock worth $350,404,000 after acquiring an additional 59,163 shares during the period. LSV Asset Management grew its holdings in shares of HCA Healthcare by 0.4% during the 2nd quarter. LSV Asset Management now owns 868,849 shares of the company’s stock worth $332,856,000 after purchasing an additional 3,396 shares in the last quarter. Finally, Schroder Investment Management Group lifted its position in HCA Healthcare by 1.9% during the second quarter. Schroder Investment Management Group now owns 676,225 shares of the company’s stock worth $259,062,000 after purchasing an additional 12,515 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages have recently commented on HCA. Wells Fargo & Company upped their price target on shares of HCA Healthcare from $412.00 to $431.00 and gave the stock an “equal weight” rating in a report on Thursday, November 13th. Mizuho raised their target price on HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a report on Thursday, December 18th. KeyCorp upped their price objective on HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a report on Monday. Finally, Royal Bank Of Canada upped their price objective on shares of HCA Healthcare from $482.00 to $525.00 and gave the stock an “outperform” rating in a research report on Friday, December 19th. Fourteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $479.00.

HCA Healthcare Price Performance

NYSE:HCA opened at $474.06 on Friday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The firm’s 50-day moving average price is $474.62 and its 200-day moving average price is $419.32. The company has a market capitalization of $108.18 billion, a PE ratio of 18.32, a P/E/G ratio of 1.40 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the prior year, the company earned $4.90 earnings per share. The business’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.